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In this study, alterations in brain perfusion have been investigated in patients with 
Tourette syndrome (TS) compared with control subjects. In addition, we investigated 
the effects of deep brain stimulation (DBS) in both globus pallidus internus (GPi) and 
centromedian-parafascicular/ventralis oralis internus nuclei of the thalamus (CM/Voi) and 
sham (SHAM) stimulation on cerebral blood flow. In a prospective controlled, random-
ized, double-blind setting, five severely affected adult patients with TS with predominant 
motor or vocal tics (mean total tic score on the Yale Global Tic Severity Scale: 39) 
underwent serial brain perfusion single photon emission computed tomography with 
99mTc-ECD. Results were compared with data from six age-matched control subjects. 
All patients were investigated at four different time points: once before DBS implanta-
tion (preOP) and three times postoperatively. Postoperative scans were performed in 
a randomized order, each after 3 months of either GPi, CM/Voi, or SHAM stimulation. 
At each investigation, patients were injected at rest while awake, but scanned during 
anesthesia. This procedure ensured that neither anesthesia nor movement artifacts 
influenced our results. Control subjects were investigated only once at baseline (without 
DBS or anesthesia). At baseline, cerebral blood flow was significantly reduced in patients 
with TS (preOP) compared with controls in the central region, frontal, and parietal lobe, 
specifically in Brodmann areas 1, 4–9, 30, 31, and 40. Significantly increased perfusion 
was found in the cerebellum. When comparing SHAM stimulation to preOP condition, 
we found significantly decreased perfusion in basal ganglia and thalamus, but increased 
perfusion in different parts of the frontal cortex. Compared with SHAM condition both 
GPi and thalamic stimulation resulted in a significant decrease in cerebral blood flow 
in basal ganglia and cerebellum, while perfusion in the frontal cortex was significantly 
increased. Our results provide substantial evidence that, in TS, brain perfusion is altered 
in the frontal cortex and the cerebellum and that these changes can be reversed by both 
GPi and CM/Voi DBS.
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inTrODUcTiOn
Tourette syndrome (TS) is a neuropsychiatric disorder character-
ized by the presence of chronic, fluctuating motor and vocal tics. 
It is associated with an increased risk of comorbid emotional and 
behavioral psychopathologies, including attention deficit hyper-
activity disorder (ADHD) and obsessive–compulsive disorder 
(OCD), which considerably affect one’s individual prognosis 
(1). Although it is believed that TS is an inherited condition, the 
precise underlying genetics still remain unknown (2).
The neurobiology and the pathomechanisms of TS are still not 
completely understood (3). Some studies show a predominant 
involvement of cortico-striato-thalamo-cortical (CSTC) circuits 
with links from distinct frontal cortical regions to subcortical 
structures (4, 5). Tics are thought to be secondary to focal excita-
tory abnormalities in the striatum, which lead to an erroneous 
inhibition of a group of neurons in the globus pallidus internus 
(GPi) and, on the other hand, to a disinhibition of cortical 
neurons (6, 7). Accordingly, neuropathological studies have 
reported on cellular alterations in the basal ganglia, such as an 
increased number of neurons in the GPi along with a reduction 
of quantity and density of neurons in the globus pallidus externus 
and nucleus caudatus (8). In addition, decreases in volume and 
microstructural changes in the thalamus have been found (9).
Alternatively, a primary cortical dysfunction has been sug-
gested, supported by different structural and functional neuro-
imaging studies. For example, hypoperfusion in frontal cortex 
areas, including prefrontal and premotor frontal cortices as well 
as the primary motor cortex, has been reported in patients with 
TS with mild to moderate tics using 15O-H2O positron emission 
tomography (PET) (10). In line with these data, volume reduc-
tions in frontal regions, reduced prefrontal cortical thickness, 
and abnormal gray matter diffusivity in the orbitofrontal cortex 
have been reported (11, 12). Recent magnetic resonance imaging 
(MRI) studies, in addition, provided evidence for an involvement 
of the SMA in tic generation (13–15). However, until today, 
it is unclear which of these abnormalities are related to the 
underlying cause of the disease and which are due to secondary 
compensatory effects.
Treatment of patients with TS is difficult and often unsatisfac-
tory. Pharmacological interventions, including antipsychotics, 
clonidine, botulinum-toxin injections as well as cannabinoids, 
neither cover the complete spectrum of symptoms nor target 
additional behavioral problems, adequately (16). Furthermore, 
available therapies are often associated with intolerable side 
effects. Therefore, deep brain stimulation (DBS) has been sug-
gested as an alternative treatment for medically refractory, 
severely affected, adult patients with TS (17). Stimulation of vari-
ous targets, including the centromedian-parafascicular/ventralis 
oralis internus nuclei of the thalamus (CM/Voi) as well as the 
GPi, resulted in beneficial clinical effects with tic improvement 
and variable amelioration of comorbidities, such as OCD, anxi-
ety, and self-injurious behavior (18–22). However, the underlying 
mechanisms of DBS in TS and its influence on abnormal cerebral 
perfusion remain unknown.
To the best of our knowledge, this is the first study investigat-
ing the impact of bilateral DBS of both the GPi and the CM/Voi 
on regional cerebral blood flow in severely affected, medically 
refractory, adult patients with TS. In order to image these severely 
affected patients, serial single photon emission computed tomog-
raphy (SPECT) with 99mTc-ECD was employed. This technique 
is feasible since the radiotracer is injected in the awake state 
and distributes according to the cerebral perfusion at the time 
of injection. Subjects may then be anesthetized for motion-free 
imaging of cerebral perfusion at the time of radiotracer injection, 
but not at the time of imaging.
MaTerials anD MeThODs
subjects
In this prospective controlled, randomized, double-blind study, 
five severely affected adult patients with TS according to DSM-
IV-TR criteria were enrolled (three women, two men, mean 
age ± SD, 29 ± 11, range, 19–47 years). Patients had to present 
with predominant and severe motor or vocal tics [total tic score 
(TTS) of the Yale Global Tic severity Scale (YGTSS) >35] (23). 
Prior interventions with at least three different medications 
(e.g., typical and atypical antipsychotics) must have had failed to 
improve the tics or resulted in intolerable side effects. Eight weeks 
before study entry and during its complete course, medication 
for the treatment of TS remained stable. Medication included 
antipsychotics (n = 4), serotonin reuptake inhibitors (n = 2), ben-
zodiazepines (n = 1), and anticholinergics (n = 1). One patient 
was free of any neurotropic medication.
Brain perfusion studies of patients were compared with those 
of six control subjects (one woman, five men, mean age ± SD, 
43 ± 8, range, 30–52 years), which represented neuropsychiatri-
cally healthy subjects with tumors of the skull base, neck, or 
throat. TS patients and controls did not significantly differ with 
respect to age and gender. All control subjects gave written-
informed consent receiving baseline brain perfusion scans 
before surgery. All patients gave written-informed consent to 
participate in the clinical study and, additionally, in the present 
imaging study. Both studies were approved by the local ethics 
committee of Hannover Medical School, and the imaging study 
also by the German Federal Office for Radiation Protection 
(trial registration identifier: Z5-22461/2-2008-006). Patients 
received extensive screening, clinical examinations, and a 
diagnostic battery consisting of neurologic, psychiatric, neu-
ropsychological, and structural MRI examinations to exclude 
diseases other than TS.
clinical assessment
All patients underwent a detailed clinical and neuropsychologi-
cal evaluation. The YGTSS was used as a semi-structured clinical 
rating instrument to evaluate the number, frequency, intensity, 
complexity, and interference of motor and vocal tics and to indi-
cate disease severity (23). Comorbid emotional and behavioral 
psychopathologies in our patients included alcoholism (n = 1), 
conduct disorder (n = 1), OCD (n = 1), subclinical OCD (n = 1), 
anxiety disorder (n = 1), and major depression (n = 1). None of 
our patients suffered from ADHD at time of investigation. Upon 
final conclusion of the clinical study with 10 patients, clinical data 
will be given in detail elsewhere.
FigUre 1 | Flow chart illustrating the study design.
3
Haense et al. Cerebral Blood Flow in Tourette
Frontiers in Psychiatry | www.frontiersin.org July 2016 | Volume 7 | Article 118
Deep Brain stimulation
Patients with TS underwent presurgical preparation in the 
Department of Neurosurgery. DBS electrodes (Medtronic 3387) 
were placed both in the posteroventral lateral GPi and in the tha-
lamic CM/Voi bilaterally, during general anesthesia in the frame 
of the clinical study protocol. Electrode placement was guided 
via CT-stereotactic surgery refined by microelectrode recording. 
In a second step, a dual channel implantable pulse generator 
(Kinetra, Medtronic) was implanted in the subclavicular region 
with a switch allowing to connect all four electrodes. Stimulation 
conditions of the electrodes (SHAM, GPi, and CM/Voi) were 
applied in a randomized order according to the study protocol 
(Figure 1). Prior to programing of DBS settings, thresholds for 
any stimulation-induced side effects were determined to allow 
blinding of the patient with subsequent subthreshold chronic 
stimulation. Each condition lasted 3 months to allow for stable 
adjustment. Patients and clinical investigators were blinded to the 
stimulation condition.
99mTc-ecD sPecT
Brain perfusion studies were performed in accordance with the 
guidelines of the European Association of Nuclear Medicine 
(EANM) (24). Before injection of 99mTc-ethyl-cysteinate-dimer 
(99mTc-ECD, Neurolite®, IBA/CIS bio GmbH, Berlin, Germany), 
patients were lying comfortable for 15 min in a quiet room with 
dimmed light. They were instructed not to speak and to relax but 
not to suppress their tics during this time and for an additional 
5 min after application of the radiopharmaceutical. Controls were 
injected under the same conditions.
Single photon emission computed tomography scanning was 
performed 1 h after injection of 550 MBq 99mTc-ECD using a dual 
head camera (ECAM variable, Siemens, Erlangen, Germany). The 
participants were positioned supine and with the canthomeatal 
line perpendicular to the rotation axis. Patients were scanned dur-
ing anesthesia to allow for motion-free acquisition. Controls were 
studied without anesthesia, but as neuropsychiatrically healthy 
subjects they were readily able to avoid head movements. Patients 
were studied four times: once before DBS implantation (preOP) 
and three time after surgery, each after 3 months of either GPi 
DBS, CM/Voi DBS, or sham stimulation (SHAM), which were 
applied in a randomized order (Figure 1). Since 99mTc-ECD was 
no longer commercially available in Germany, the enrollment 
into the imaging study had to be terminated after inclusion of 
five patients.
Data and statistical analysis
3D datasets were spatially normalized into stereotactic standard 
space according to Montreal Neurological Institute (MNI) 
using the default brain perfusion template of SPM2 (Statistical 
Parametric Mapping, Wellcome Trust Centre for Neuroimaging, 
London, UK) and employing affine and non-linear procedures 
(16 non-linear iterations, 7 ×  9 ×  7 basis functions). 3D data-
sets were smoothed (FWHM 10 mm) and rescaled to the 75th 
intensity percentile of the whole brain. Rescaled 3D datasets of 
patients and control subjects were compared based on volumes of 
interest (VOIs) as well as voxelwise to detect regional changes of 
brain perfusion. VOIs were delineated by automated anatomical 
labeling using the Cyceron and the Brodmann (BA) map of the 
brain, respectively (25).
To identify changes in larger brain regions, small VOIs 
according to Cyceron were summarized to large VOIs as fol-
lows: (i) frontal lobe =  superior, middle, inferior and orbital 
frontal gyrus, and supplementary motor area; (ii) parietal 
lobe = superior and inferior parietal gyrus, angular gyrus, and 
precuneus; (iii) temporal lobe = superior, middle and inferior 
temporal gyrus, Heschl’s gyrus, and temporal pole; (iv) limbic 
lobe = hippocampus and parahippocampus and amygdala; (v) 
cingulum =  anterior, middle, and posterior cingulate gyrus; 
(vi) occipital lobe = cuneus, lingual gyrus and superior, middle, 
and inferior occipital gyrus; (vii) central region =  precentral 
and postcentral gyrus and paracentral lobe; and (viii) cerebel-
lum. Moreover, the following regions were evaluated separately: 
caudate, putamen, pallidum, and thalamus. Always the average 
of left and right side was considered. Mean rescaled counts in 
VOIs were compared between groups (preOP vs. controls) and 
TaBle 1 | significant differences in blood flow between patients preoperatively and control subjects.
Direction of  
flow change
VOi analysis sPM analysis
large region p Brodmann  
area
p subregion Mni (x y z) Voxel Z value
Decrease Central cortex 0.0020 BA 1 0.0103 Right pre- and postcentral 36 −12 68 367 4.41
BA 4 0.0275 Left paracentral −14 −54 78 143 4.28
Decrease Frontal cortex 0.0138 BA 6 0.0001 Bilateral SMA, superior frontal −10 20 60 335 4.43
BA 8 <0.0001 Right middle frontal 38 8 64 245 4.15
BA 9 0.0012
Decrease Parietal cortex 0.0026 BA 5 0.0388 Bilateral precuneus −6 −50 56 277 3.98
BA 7 0.0090 Left superior parietal, inferior parietal,  
angular gyrus
−40 −64 60 253 4.48
BA 40 0.0017 Right superior parietal 32 −54 68 146 4.10
Right inferior parietal, angular gyrus 54 −62 46 47 4.29
Decrease BA 30 0.0416
BA 31 0.0050
Increase Cerebellum 0.0079 Right cerebellum 16 −70 32 124 4.01
Left cerebellum 0 −18 −34 153 3.57
4
Haense et al. Cerebral Blood Flow in Tourette
Frontiers in Psychiatry | www.frontiersin.org July 2016 | Volume 7 | Article 118
conditions (e.g., GPi vs. SHAM) using t-tests for independent 
and paired samples with a threshold of at least p <  0.05 for 
significance, respectively. Voxelwise comparisons were done 
using SPM2 with combined thresholds for statistical inferences 
of p = 0.001 on voxel level and p = 0.01 on cluster level (uncor-
rected p-values).
resUlTs
clinical assessment
There were no surgical complications. Postoperative stereotactic 
computed tomography (CT) confirmed DBS electrode placement 
in all patients. Before DBS (preOP), patients had a mean YGTSS-
TTS (±SD) of 39 (±5). During all postoperative conditions, the 
mean YGTSS-TTS was reduced  –  GPi: 33 (±10), CM/Voi: 33 
(±14), SHAM 31 (±13). There were no significant differences 
between conditions. Detailed results will be reported elsewhere 
after completion of the study including n = 10 patients.
cerebral Perfusion – Patients vs. controls
In patients with TS preOP compared with control subjects, 
analysis of large VOIs showed significantly decreased cerebral 
perfusion in the central region, the frontal lobe, and the parietal 
lobe (Table 1). Cerebellar perfusion was significantly increased.
With respect to BA, significant flow reductions were detected 
likewise in the central region (BA 1and BA 4), the frontal cortex 
(BA 6, including the SMA, BA 8, and BA 9), the parietal cortex 
(BA 5, BA 7, and BA 40), and in the posterior cingulum (BA 30 
and BA 31).
SPM analysis showed correspondingly decreased perfusion in 
the central cortex (right pre- and postcentral, left paracentral), 
the frontal cortex (bilateral SMA, bilateral superior frontal cortex, 
and right middle frontal gyrus), and the parietal cortex (bilateral 
precuneus as well as bilateral superior, inferior and angular 
gyrus). Perfusion was increased in the left temporal cortex and 
bilaterally in the cerebellum. Results of SPM analysis are given in 
Table 1 and displayed in Figure 2.
cerebral Perfusion – shaM vs. preOP
When comparing SHAM to preOP condition, VOI analysis 
showed decreased perfusion in the thalamus, putamen, pallidum, 
anterior and posterior cingulate (BA29, BA33), as well as inferior 
frontal cortex (BA44, BA45) (Table  2). SPM analysis, likewise, 
revealed reduced perfusion in the basal ganglia, thalamus, and 
cingulum (left caudate, putamen, anterior and middle cingulum, 
right thalamus), as well as frontal cortex (left inferior, right mid-
dle, and superior gyrus). Areas of decreased perfusion detected 
in SPM analysis are shown in Figure  3 and listed in Table  2. 
Increased perfusion during SHAM condition was found in VOI 
analysis only in the occipital cortex (BA17). Using SPM, we 
detected higher perfusion in the right SMA, temporal (superior, 
middle gyrus), and left occipital cortex.
cerebral Perfusion – gPi stimulation vs. 
preOP and shaM, respectively
During GPi stimulation, compared with preOP condition, blood 
flow was reduced according to VOI analysis in the thalamus, 
putamen, pallidum, and cerebellum (Table  3). SPM analysis 
largely confirmed lower perfusion in thalamus, basal ganglia, 
and cerebellum (right thalamus, caudate, putamen, insula, frontal 
inferior gyrus, left pallidum, putamen, cerebellum bilaterally) 
(Table  3). Moreover, perfusion was decreased in the temporal 
cortex (right middle gyrus, hippocampus, left middle gyrus). 
Figure 4 shows areas of reduced perfusion. No increases of perfu-
sion were found.
When comparing GPi stimulation to SHAM condition, again 
flow reductions in the basal ganglia, thalamus, and cerebellum 
were observed (VOI analysis: putamen, SPM analysis: right puta-
men, caudate, thalamus, cerebellum, left putamen, frontal supra 
orbital gyrus, insula, and cerebellum). Furthermore, perfusion 
was decreased in the temporal lobe (left inferior, superior, fusi-
form gyrus, right pole, inferior gyrus) and left cuneus (Table 3). 
Blood flow increases were seen in the right frontal cortex (supe-
rior, middle gyrus), bilateral precuneus, and bilateral middle and 
right anterior cingulum.
FigUre 2 | comparison of cerebral perfusion between patients and 
controls. Statistical parametric map (extent threshold k = 124 voxel) 
projected onto surface display of MRT in MNI stereotactic space. Decreased 
blood flow (blue) in patients was evident in frontal, central, and parietal 
cortex, while increased flow (red) was present in the cerebellum.
TaBle 2 | significant differences in blood flow between patients during 
shaM condition vs. preoperatively.
Direction 
of flow 
change
VOi analysis sPM analysis
region p region Mni  
(x y z)
Voxel Z  
value
Decrease Thalamus 0.0143 Left caudate, 
left putamen, 
right thalamus, 
left anterior 
cingulate
−6 0 16 420 4.78
Putamen 0.0247
Pallidum 0.0308
BA 29 0.0383 Left middle 
cingulate
−2 12 38 66 4.28
BA 33 0.0382
Decrease BA 44 0.0190 Left inferior 
frontal cortex
−58 22 4 55 4.20
BA 45 0.0349
Decrease Middle and 
superior  
frontal cortex
34 66 0 13 3.66
Increase BA 17 0.0372 Calcarine, 
cuneus
−4 −76 20 25 3.72
Increase Right SMA, 
middle  
cingulate
14 −8 50 29 4.30
Superior,  
middle  
temporal  
cortex
74 −30 0 42 4.06
FigUre 3 | reduction of cerebral perfusion after DBs electrode 
placement during shaM condition compared with preOP. An extended 
flow reduction was observed encompassing multiple areas within basal 
ganglia and thalamus (extent threshold k = 23 voxel).
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cerebral Perfusion – cM/Voi stimulation 
vs. preOP and shaM, respectively
Comparing CM/Voi stimulation to preOP condition, SPM analy-
sis showed reduced blood flow in the right caudate, left inferior 
frontal cortex, and right middle and superior temporal gyrus. 
Flow was increased in the left paracentral lobe, right pre-, post-, 
and supramarginal gyrus, and middle frontal gyrus (Table  4). 
Comparison of CM/Voi to SHAM stimulation showed flow 
decreases bilaterally in the cerebellum, left middle occipital gyrus, 
right middle and superior temporal gyrus, and right fusiform 
gyrus. Increased flow was detected in the left frontal superior 
gyrus, SMA and frontal middle gyrus, left pre- and postcentral 
gyrus, and the left inferior parietal and postcentral gyrus. Figure 5 
shows blood flow changes during CM/Voi compared with SHAM 
stimulation detected with SPM. VOI analysis confirmed reduced 
flow in the cerebellum and occipital cortex (BA19), as well as 
increased flow in the frontal cortex (BA10) (Table 4).
DiscUssiOn
We investigated regional cerebral perfusion patterns in patients 
with TS not only compared with neuropsychiatrically healthy 
control subjects but also during different conditions of DBS. To 
the best of our knowledge, this is the first neuroimaging study 
investigating TS patients suffering from extreme tics  –  those 
patients who are usually excluded from imaging studies due 
to unavoidable motion artifacts. Since image acquisition had 
been carried out during anesthesia, movement artifacts could 
FigUre 4 | reduction of cerebral perfusion after DBs electrode 
placement during gPi stimulation compared with preOP. Additionally to 
flow reductions in the basal ganglia and thalamus as detected during SHAM 
condition (see Figure 3) GPi stimulation resulted into reduced flow within the 
cerebellum (extent threshold k = 13).
TaBle 3 | significant differences in blood flow between patients during gPi condition vs. preoperatively and shaM condition.
comparison Direction of  
flow change
VOi analysis sPM analysis
region p region Min (x y z) Voxel Z value
GPi vs. preOP Decrease Thalamus 0.0365 Right thalamus 2 −12 18 147 4.12
Decrease Putamen 0.0187 Right caudate, putamen, insula, inferior frontal cortex 30 22 6 100 5.27
Decrease Pallidum 0.0167 Left pallidum, putamen −16 2 0 126 3.90
Decrease Cerebellum 0.0418 Right cerebellum 56 46 −32 47 3.96
Left cerebellum −24 −58 −20 39 4.10
Decrease Right middle temporal cortex 66 −42 2 40 4.08
Right hippocampus 18 −34 −6 27 4.04
Left middle temporal cortex −56 −52 −4 29 4.16
GPi vs. SHAM Decrease Putamen 0.0384 Right putamen 30 20 −2 46 3.82
Left putamen, supra orbital frontal cortex, insula −26 8 −10 40 3.30
Decrease Right caudate 10 10 −6 29 3.76
Right thalamus 6 −14 8 20 3.64
Decrease Right cerebellum 48 −68 −24 48 3.86
Left cerebellum −24 −86 −32 24 3.93
Decrease Left inferior and middle temporal cortex −46 −22 −38 75 4.79
Left fusiform gyrus −34 −60 −2 51 4.72
Right temporal pole and inferior cortex 42 6 −36 31 3.65
Left cuneus −6 −82 18 32 3.93
Increase Superior and middle frontal cortex 28 42 44 39 3.65
Precuneus bilateral 4 −52 44 20 4.17
Bilateral middle and right anterior cingulate 0 −4 32 33 4.47
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be completely excluded. Anesthesia, however, did also not influ-
ence our image data, since tracer injection was done in awake 
condition. Finally, also influences by age and gender could be 
excluded, confirming that changes in cerebral perfusion patterns 
were due to the pathophysiology of patients with severe TS and 
not related to demographic characteristics.
Before implantation of the electrodes, patients with TS showed 
hypoperfusion in central regions, including the primary motor 
cortex and the postcentral gyrus, regions of the frontal cortex, 
including the superior and medial frontal gyrus, and the sup-
plementary motor area, as well as parts of the parietal lobe when 
compared with control subjects. These findings are in line with 
previous reports of less affected patients demonstrating hypop-
erfusion in regions of the frontal cortex and the primary motor 
cortex using 99mTc-ECD SPECT and 15O-H2O PET, respectively 
(10, 26). Using anatomical MRI, reduced cortical thickness of 
sensorimotor cortices as well as gray matter volume reduction 
of frontal regions could be demonstrated, pointing to a possible 
involvement of the frontal cortex in the pathology of TS (11, 27). 
In TS, it is assumed that especially regions of the frontal lobe and 
the central cortex are predominantly affected, which are involved 
in planning, controlling, and regulating the movements. Thus, 
from available data, it is suggested that, in TS, inhibitory mecha-
nisms necessary for motor control are insufficient.
We also found an increased perfusion in the cerebellum 
in patients with TS compared with control subjects. This 
finding is in line with recent studies using 15O-H2O PET, 
18F-fluorodeoxyglucose-PET, and event-related functional (f)
MRI reporting about an involvement of the cerebellum in TS 
pathology (28–30). Since the CSTC network is supposed to 
play a major role in the pathophysiology of TS, the cerebellum 
has been suggested being a “second-in-line” structure affected 
by disturbed connections of the network (28). It has been 
hypothesized that the cerebellum is involved not only in motor 
execution and initiation of tics but also in the sensation of pre-
monitory urges before the tics (28). Since the cerebellum has 
multiple connections to the basal ganglia and the thalamus, it 
has also been suggested that an overactivity of the cerebellum 
TaBle 4 | significant differences in blood flow between patients during cM/Voi condition vs. preoperatively and shaM condition.
comparison Direction of  
flow change
VOi analysis sPM analysis
region p region Min (x y z) Voxel Z value
CM/Voi vs.  
preOP
Decrease Right caudate 16 4 26 71 3.32
Left inferior frontal cortex −54 18 4 37 4.21
Right middle and superior temporal cortex 50 −16 −14 24 3.94
Increase Left paracentral lobe −10 −22 86 148 4.59
Right pre-, post-, and supramarginal gyrus 46 −30 40 98 4.43
Middle frontal cortex −52 12 46 37 4.25
CM/Voi vs.  
SHAM
Decrease Cerebellum 0.0055 Left cerebellum −4 −68 −28 170 4.67
Right cerebellum 46 −60 −20 23 3.70
Decrease BA 19 0.0486 Left middle occipital cortex −28 −96 14 27 3.87
Decrease Right middle and superior temporal cortex 52 −16 −18 123 4.85
Right fusiform gyrus 24 −62 −14 20 3.63
Increase BA 10 0.0012 Left superior frontal cortex −18 0 78 45 4.05
Left SMA and middle frontal cortex −22 14 50 29 3.67
Increase Left pre- and postcentral cortex −48 −6 56 82 4.29
Left inferior parietal and postcentral cortex −30 −44 38 26 4.26
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contributes not only to the origin of tics but also to common 
psychiatric comorbidities, such as ADHD and OCD (28). This 
hypothesis is supported by data obtained from patients suffering 
from pure OCD, which demonstrated increased gray matter 
volumes bilaterally in the anterior cerebellum (31). Furthermore, 
data from patients with pure ADHD showed reduced cerebellar 
activity using fMRI (32). Our findings of an increased cerebellar 
perfusion in TS preOP compared with control subjects, as well 
as a significant decrease of the cerebellar perfusion during both 
GPi and CM/Voi stimulation compared with SHAM condition 
further corroborate the hypothesis that the cerebellum is patho-
physiologically involved in the primary cause of TS. Accordingly, 
the cerebellum has been suggested as a vitally important target 
for therapeutic interventions in TS (33).
To investigate the influence of the implantation of the elec-
trodes per  se on cerebral perfusion, we compared the SHAM 
condition with the preOP status. As expected, the main finding 
was a decrease of the cerebral blood flow in the target regions 
(GPi and CM/Voi). These findings are most likely correlates of a 
“microlesional effect.” Our results correspond to those reported 
by Hilker et al. (34) in patients with Parkinson’s disease, which 
demonstrated hypometabolism in the subthalamic nucleus dur-
ing the “off condition” 6 months after implantation of electrodes 
in this target area (34). However, during SHAM condition, we 
also observed a unilateral increase of cerebral perfusion in the 
SMA (a brain area known to be relevant for motor control) 
suggesting that even the mere implantation of DBS electrodes 
(without stimulation) might influence TS pathophysiology. 
One can speculate that clinical improvement during SHAM 
stimulation – as detected in this study – might be related to such 
changes. Remarkably, tic severity was reduced both during the 
SHAM condition and during GPi and CM/Voi stimulation. We 
believe that it would be premature to draw any conclusions from 
these preliminary findings, which might be related to various 
issues, such as the low number of patients included, a placebo 
effect, the spontaneous fluctuations in tic severity, and the 
implications of subjectivity on tic assessments. We are confident 
to clarify this issue upon conclusion of the clinical study after 
inclusion of a larger sample size and assessing all available clini-
cal evaluations, including video protocols and other measures.
During both GPi and CM/Voi stimulation, a more extended 
increase of cerebral perfusion (compared with SHAM condition) 
was found in different regions of the frontal cortex: in the right 
FigUre 5 | comparison of cerebral perfusion with cM/Voi 
stimulation vs. shaM. Effective stimulation resulted in flow reductions in 
the cerebellum and increases in the central and frontal cortex, specifically 
encompassing the SMA.
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superior and middle frontal area, during GPi stimulation, and 
in the left superior as well as middle frontal gyrus and supple-
mentary motor area, during CM/Voi stimulation. This finding 
could be interpreted as a step toward “normalization” of abnor-
mal perfusion in the frontal cortex in TS, since cerebral blood 
flow was decreased in this region in TS preOP compared with 
control subjects. It can be speculated that the increase in cerebral 
perfusion in frontal regions reflects an improved motor control 
resulting in a clinical improvement, specifically a tic reduction. 
Interestingly, this finding is in accordance with a study reporting 
on an increased perfusion of orbital and anterior medial regions 
of the frontal lobe bilaterally during successful neuroleptic treat-
ment of tics in young patients with TS (35).
In addition, we found significant decreases of cerebral perfu-
sion during GPi and CM/Voi stimulation compared with SHAM 
condition in the cerebellum and basal ganglia. As discussed 
earlier, abnormalities in the cerebellum have even been proposed 
as being the primary cause of TS (28). It can be hypothesized 
that both CM/Voi and GPi DBS have an impact on the possibly 
detrimental excitatory signaling between the cerebellum and the 
striatum and, therefore, result in clinical improvement.
In contrast to studies investigating less severely affected 
Tourette patients, we did not observe significant hypoperfu-
sion in the basal ganglia (26, 36, 37). One possible explanation, 
which has not been investigated thus far, would be a difference 
in perfusion during the presence of tics vs. that in patients trying 
to suppress tic activity. Moreover, effects of medication, namely 
antipsychotic treatment, performed in all but one patient, cannot 
be ruled out. However, at least in patients with schizophrenia, 
conflicting results of either decreased or increased brain perfu-
sion in the frontal cortex due to treatment with antipsychotics 
have been reported (38, 39).
Although our study provides objective data on the impact of 
DBS electrode implantation and chronic subthreshold stimula-
tion, several limitations have to be addressed. The sample size 
was rather small. The patient group was heterogeneous with 
respect to comorbidities, which might hamper the validity of 
the comparison with the control group. DBS did not result in a 
statistically significant tic improvement compared with SHAM 
stimulation. Furthermore, from our data, no conclusion can be 
drawn whether certain patterns or changes in cerebral perfusion 
in specific brain areas can be used to predict individual treatment 
responses to DBS.
cOnclUsiOn
Pathologically reduced frontal cortex perfusion in patients with 
severe TS can be reversed by GPi and CM/Voi DBS. In addition, 
both types of DBS reduce abnormally increased cerebellar perfu-
sion. Our data, therefore, provide substantial evidence that, in TS, 
both GPi and CM/Voi DBS not only result in similar alterations of 
cerebral blood flow but also cause changes toward normalization.
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